Organization
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
9 clinical trials
Clinical trial
A Single-center, Prospective Study of the Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant Non-small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Single-Center, Prospective, Single-Arm, Observational Study Evaluating the Efficacy and Safety of Osimertinib Combined With Etoposide as First-Line Treatment in Patients With Osimertinib-Resistant or -Insensitive, Advanced EGFR-Mutant Non-Small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2029-06-01
Clinical trial
Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal CancerStatus: , Estimated PCD: 2024-02-01
Clinical trial
S-1 Combined With Tislelizumab in Patients With Primary Residual Node-negative Esophageal Squamous Cell Carcinoma (ESCC) After Radical Resection With Neoadjuvant Immunotherapy Combined With Chemotherapy, PHASE II STUDYStatus: Recruiting, Estimated PCD: 2027-04-30
Clinical trial
An Observational Phase II Study to Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib in Advanced Non-small Cell Lung Cancer Patients With BRAF V600E MutationStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Clinical trial
Clinical Application of Efficacy Prediction Model Based on Epigenetics Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal TumorsStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Phase II Study Evaluating Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated Non-small Cell Lung Cancer (NSCLC)Status: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection：a Randomized-control TrialStatus: Withdrawn, Estimated PCD: 2022-12-30
Clinical trial
Stem Cells for Bronchopulmonary Dysplasia: a Cohort StudyStatus: Withdrawn, Estimated PCD: 2022-12-30